Qube Research & Technologies LTD Corcept Therapeutics Inc Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 58,529 shares of CORT stock, worth $2.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,529
Holding current value
$2.92 Million
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$29.51 - $46.26 $1.73 Million - $2.71 Million
58,529 New
58,529 $2.71 Million
Q1 2024

May 14, 2024
BUY
$21.1 - $27.46 $3.03 Million - $3.95 Million
143,747 New
143,747 $3.62 Million
Q3 2023

Nov 13, 2023
SELL
$21.97 - $33.8 $2.27 Million - $3.5 Million
-103,442 Reduced 98.09%
2,009 $54,000
Q2 2023

Aug 14, 2023
BUY
$21.44 - $25.15 $1.62 Million - $1.9 Million
75,650 Added 253.85%
105,451 $2.35 Million
Q1 2023

May 15, 2023
SELL
$19.2 - $24.47 $2.05 Million - $2.62 Million
-106,963 Reduced 78.21%
29,801 $645,000
Q4 2022

Feb 14, 2023
BUY
$19.95 - $29.96 $1.19 Million - $1.79 Million
59,881 Added 77.89%
136,764 $2.78 Million
Q3 2022

Nov 14, 2022
BUY
$24.7 - $29.12 $1.11 Million - $1.31 Million
45,079 Added 141.74%
76,883 $1.97 Million
Q2 2022

Aug 15, 2022
SELL
$17.33 - $25.3 $151,845 - $221,678
-8,762 Reduced 21.6%
31,804 $756,000
Q1 2022

May 09, 2022
SELL
$16.53 - $25.21 $27,423 - $41,823
-1,659 Reduced 3.93%
40,566 $914,000
Q4 2021

Feb 01, 2022
BUY
$17.1 - $23.34 $214,776 - $293,150
12,560 Added 42.34%
42,225 $836,000
Q3 2021

Nov 12, 2021
BUY
$19.68 - $22.53 $583,807 - $668,352
29,665 New
29,665 $584,000
Q2 2021

Aug 13, 2021
SELL
$19.97 - $24.43 $318,221 - $389,292
-15,935 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$23.49 - $30.56 $374,313 - $486,973
15,935 New
15,935 $379,000
Q3 2020

Nov 12, 2020
SELL
$12.46 - $19.98 $262,532 - $420,978
-21,070 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$11.0 - $18.26 $88,748 - $147,321
8,068 Added 62.05%
21,070 $354,000
Q1 2020

May 15, 2020
BUY
$10.11 - $14.04 $131,450 - $182,548
13,002 New
13,002 $155,000

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.1M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.34B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email